| PTLE 0.282 51.53% | SOXS 3.65 11.56% | MSPR 0.664 27.57% | SCNX 0.8182 15.35% | NVDA 198.69 -3.96% | SQQQ 13.79 6.16% | ORIS 0.1603 -0.12% | BYND 1.33 -4.32% | PFE 24.3 -1.46% | HTZ 6.73 36.23% | PLTR 190.74 -7.94% | TSLL 20.34 -10.16% | ETHA 24.28 -10.37% | ASST 1.25 -1.57% | IBIT 57.18 -5.53% | GRAB 5.785 -4.70% | INTC 37.03 -6.25% | PLUG 2.52 -8.36% | ONDS 5.96 -3.09% | OPEN 6.92 -8.83% | CHR 0.136 8.11% | FGL 0.5165 26.94% | DNN 2.74 -6.00% | TSLA 444.26 -5.15% | WTO 0.0497 -6.23% | CAPT 0.6615 31.77% | NFE 1.35 14.41% | SOXL 42.8 -11.90% | BITF 3.84 -6.57% | ETHD 5.26 20.92% | T 24.44 -0.37% | EPWK 0.0748 3.60% | F 12.79 -1.69% | SPY 675.24 -1.19% | SOFI 29.37 -4.11% | KVUE 15.97 -1.05% | ACHR 9.56 -8.25% | CIFR 22.51 -1.10% | QQQ 619.25 -2.03% | HIMS 42.79 -3.60% | GPUS 0.3494 -7.03% | TQQQ 111.08 -6.12% | LQD 110.68 0.14% | BTBT 3.18 -7.02% | AAL 12.65 -5.17% | TZA 8.21 5.26% | BURU 0.29 -7.91% | NCLH 18.79 -15.28% | RGTI 35.18 -10.07% | BTG 4 -5.77%

Cohen & Steers, Inc. (NYSE: CNS) Quarterly Earnings Preview

Cohen & Steers, Inc. (NYSE: CNS) is a global investment manager specializing in real assets and alternative income. Founded in 1986 and headquartered in New York City, CNS operates in major financial hubs worldwide. The company's focus areas include real estate, preferred securities, and infrastructure, positioning it as a significant entity in the investment management sector.

CNS is poised to release its quarterly earnings on Thursday, July 17, 2025. Wall Street forecasts an EPS of $0.75, with anticipated revenue of around $135.5 million. The company recently announced that its assets under management had reached $88.9 billion as of June 30, 2025, an increase of $321 million from the previous month, primarily due to market appreciation of $965 million.

Despite this positive trend, CNS encountered challenges, including distributions totaling $460 million and net outflows of $184 million, which partially offset asset growth. The company's financial metrics, such as a P/E ratio of 24.16 and a price-to-sales ratio of 6.95, alongside an enterprise value to sales ratio of 6.83, reflect the market's valuation of its earnings and revenue. Furthermore, CNS boasts a strong current ratio of 20.91, indicating its robust ability to cover short-term liabilities and providing confidence in its financial stability. With an earnings yield of 4.14%, CNS offers insight into the return on investment for shareholders.

The upcoming earnings release will be available on the company's website, followed by a conference call on Friday, July 18, 2025, at 10:00 a.m. Eastern Time. CEO Joseph Harvey, CFO Raja Dakkuri, and President and Chief Investment Officer Jon Cheigh will discuss the company's operating results and future outlook. Investors can join the call via webcast or telephone, using the provided passcode, to gain further insights into CNS's financial performance and strategic direction.

Published on: July 16, 2025